89.79
前日終値:
$90.78
開ける:
$91.05
24時間の取引高:
173.71K
Relative Volume:
0.38
時価総額:
$1.95B
収益:
$486.82M
当期純損益:
$18.78M
株価収益率:
109.50
EPS:
0.82
ネットキャッシュフロー:
$100.45M
1週間 パフォーマンス:
+0.17%
1か月 パフォーマンス:
-7.87%
6か月 パフォーマンス:
+37.88%
1年 パフォーマンス:
+62.96%
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
名前
Ani Pharmaceuticals Inc
セクター
電話
(218) 634-3500
住所
210 MAIN STREET WEST, BAUDETTE, MN
ANIP を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ANIP
Ani Pharmaceuticals Inc
|
89.79 | 2.02B | 486.82M | 18.78M | 100.45M | 0.82 |
![]()
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
![]()
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
![]()
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-10 | 開始されました | H.C. Wainwright | Buy |
2025-03-14 | 開始されました | Jefferies | Buy |
2025-03-12 | 開始されました | JP Morgan | Overweight |
2024-12-11 | 開始されました | Leerink Partners | Outperform |
2024-10-11 | 開始されました | Piper Sandler | Overweight |
2024-03-15 | 開始されました | CapitalOne | Overweight |
2023-08-22 | 繰り返されました | H.C. Wainwright | Buy |
2023-03-01 | 開始されました | Guggenheim | Buy |
2022-09-07 | 開始されました | H.C. Wainwright | Buy |
2021-11-02 | 開始されました | Truist | Buy |
2020-05-07 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2019-09-12 | 開始されました | Guggenheim | Buy |
2019-05-10 | ダウングレード | Raymond James | Strong Buy → Outperform |
2017-10-16 | 繰り返されました | Canaccord Genuity | Buy |
2017-07-31 | 開始されました | Canaccord Genuity | Buy |
2017-02-22 | ダウングレード | ROTH Capital | Buy → Neutral |
2016-06-23 | 開始されました | Raymond James | Strong Buy |
2016-05-24 | ダウングレード | Standpoint Research | Buy → Hold |
2015-11-13 | 開始されました | Standpoint Research | Buy |
2015-09-28 | アップグレード | ROTH Capital | Neutral → Buy |
2015-08-05 | 繰り返されました | Oppenheimer | Outperform |
2015-08-04 | 繰り返されました | ROTH Capital | Neutral |
2015-07-31 | 繰り返されました | Oppenheimer | Outperform |
2015-07-15 | 繰り返されました | ROTH Capital | Neutral |
2015-06-23 | 繰り返されました | Oppenheimer | Outperform |
2015-05-18 | 繰り返されました | ROTH Capital | Neutral |
2015-05-06 | 繰り返されました | Oppenheimer | Outperform |
2015-04-10 | ダウングレード | ROTH Capital | Buy → Neutral |
2015-02-26 | 繰り返されました | ROTH Capital | Buy |
2015-02-18 | 繰り返されました | Oppenheimer | Outperform |
すべてを表示
Ani Pharmaceuticals Inc (ANIP) 最新ニュース
Is ANI Pharmaceuticals Inc. a candidate for recovery play2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
Truist Financial Issues Positive Forecast for ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price - MarketBeat
Visualizing ANI Pharmaceuticals Inc. stock with heatmaps2025 Price Targets & Weekly High Momentum Picks - newser.com
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? - Yahoo Finance
ANI Pharmaceuticals Inc. stock trend forecastTrade Signal Summary & Daily Technical Forecast Reports - newser.com
What recovery options are there for ANI Pharmaceuticals Inc.Portfolio Growth Summary & Weekly Top Gainers Trade List - newser.com
Will a bounce in ANI Pharmaceuticals Inc. offer an exitQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com
How ANI Pharmaceuticals Inc. (BSFA) stock compares with tech leaders2025 Price Momentum & Consistent Income Trade Ideas - newser.com
Analyzing recovery setups for ANI Pharmaceuticals Inc. investors2025 Year in Review & Technical Confirmation Trade Alerts - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock beat value stocksQuarterly Profit Report & Pattern Based Trade Signal System - newser.com
Is ANI Pharmaceuticals Inc. stock undervalued vs historical averages2025 Earnings Surprises & Fast Momentum Entry Tips - newser.com
ANI Pharmaceuticals (NASDAQ:ANIP) Downgraded to "Sell (D+)" Rating by Weiss Ratings - MarketBeat
ANI Pharmaceuticals (ANIP): Buy, Sell, Or Hold Post Q2 Earnings? - Barchart.com
ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q2 Earnings? - The Globe and Mail
Can ANI Pharmaceuticals Inc. stock deliver strong Q4 earnings2025 Technical Patterns & Risk Managed Investment Signals - newser.com
Institutional scanner results for ANI Pharmaceuticals Inc.Bond Market & Low Drawdown Trading Strategies - newser.com
Can ANI Pharmaceuticals Inc. stock sustain revenue growth2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com
Live market analysis of ANI Pharmaceuticals Inc.Weekly Gains Summary & Technical Buy Zone Confirmations - newser.com
Is a relief rally coming for ANI Pharmaceuticals Inc. holdersWeekly Investment Report & Weekly Top Gainers Alerts - newser.com
What moving averages say about ANI Pharmaceuticals Inc.Short Setup & Fast Gain Stock Trading Tips - newser.com
A Fresh Look at ANI Pharmaceuticals (ANIP) Valuation as Quiet Market Moves Draw Investor Interest - Yahoo Finance
What analysts say about ANI Pharmaceuticals Inc stockLong-Term Investment Plans & Swing Trade Smarter With Data Insights - earlytimes.in
Assenagon Asset Management S.A. Sells 101,728 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Ani Pharmaceuticals Inc (ANIP) 財務データ
収益
当期純利益
現金流量
EPS
Ani Pharmaceuticals Inc (ANIP) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. |
Sep 12 '25 |
Sale |
98.42 |
400 |
39,368 |
76,074 |
Pera Antonio R | Director |
Sep 03 '25 |
Sale |
94.94 |
7,292 |
692,302 |
22,660 |
大文字化:
|
ボリューム (24 時間):